Skip to main content
SRPT logo
SRPT
(NASDAQ)
Sarepta Therapeutics, Inc.
$23.23-- (--)
Loading... - Market loading

Sarepta Therapeutics, Inc. (SRPT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Sarepta Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(10 total ratings in last 90 days)
Medium Confidence1.3:1 Buy/Sell

Average Price Target

$26.33
13.34% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest SRPT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Yigal Nochomovitz
Citi
Strong SellMaintains
$9.00 $13.00
Gil Blum
Needham
SellReiterates
-
Kostas Biliouris
Oppenheimer
BuyReiterates
$37.00 $37.00
Uy Ear
Mizuho
BuyMaintains
$26.00 $31.00
Yigal Nochomovitz
Citi
Strong SellMaintains
$8.00 $9.00
Mitchell S. Kapoor
HC Wainwright
Strong SellReiterates
$5.00 $5.00
Yanan Zhu
Wells Fargo
BuyMaintains
$45.00 $38.00
Mitchell S. Kapoor
HC Wainwright
Strong SellReiterates
$5.00 $5.00
Yun Zhong
Wedbush
BuyMaintains
$32.00 $34.00
Mitchell S. Kapoor
HC Wainwright
Strong SellReiterates
$5.00 $5.00

Frequently Asked Questions

What is the analyst consensus rating for SRPT?

The analyst consensus rating for SRPT is "Buy" based on 7 analyst recommendations.

What is the average price target for SRPT?

The average 12-month price target for SRPT is $26.33, representing an upside of 13.3% from the current price of $23.23.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.